Imatinib is a targeted cancer drug that is used to treat a variety of diseases, including chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and acute lymphoblastic leukemia (ALL). It is also known by the trade names Gleevec and Glivec. If you are a manufacturer or supplier of Imatinib, you can find a list of global buyers in this article. The list includes the contact information, website, and product requirements of each buyer. This information will help you connect with potential customers and grow your business. The list of global buyers is updated regularly to ensure that you have the most up-to-date information. You can also use the search bar…